These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 20805261)

  • 1. Characteristics of beryllium exposure to small particles at a beryllium production facility.
    Virji MA; Stefaniak AB; Day GA; Stanton ML; Kent MS; Kreiss K; Schuler CR
    Ann Occup Hyg; 2011 Jan; 55(1):70-85. PubMed ID: 20805261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is total mass or mass of alveolar-deposited airborne particles of beryllium a better predictor of the prevalence of disease? A preliminary study of a beryllium processing facility.
    Kent MS; Robins TG; Madl AK
    Appl Occup Environ Hyg; 2001 May; 16(5):539-58. PubMed ID: 11370934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensitization and chronic beryllium disease at a primary manufacturing facility, part 1: historical exposure reconstruction.
    Virji MA; Park JY; Stefaniak AB; Stanton ML; Day GA; Kent MS; Kreiss K; Schuler CR
    Scand J Work Environ Health; 2012 May; 38(3):247-58. PubMed ID: 21850365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison and critique of historical and current exposure assessment methods for beryllium: implications for evaluating risk of chronic beryllium disease.
    Kolanz ME; Madl AK; Kelsh MA; Kent MS; Kalmes RM; Paustenbach DJ
    Appl Occup Environ Hyg; 2001 May; 16(5):593-614. PubMed ID: 11370938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exposure-response analysis for beryllium sensitization and chronic beryllium disease among workers in a beryllium metal machining plant.
    Madl AK; Unice K; Brown JL; Kolanz ME; Kent MS
    J Occup Environ Hyg; 2007 Jun; 4(6):448-66. PubMed ID: 17474035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physicochemical characteristics of aerosol particles generated during the milling of beryllium silicate ores: implications for risk assessment.
    Stefaniak AB; Chipera SJ; Day GA; Sabey P; Dickerson RM; Sbarra DC; Duling MG; Lawrence RB; Stanton ML; Scripsick RC
    J Toxicol Environ Health A; 2008; 71(22):1468-81. PubMed ID: 18836922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exposure pathway assessment at a copper-beryllium alloy facility.
    Day GA; Dufresne A; Stefaniak AB; Schuler CR; Stanton ML; Miller WE; Kent MS; Deubner DC; Kreiss K; Hoover MD
    Ann Occup Hyg; 2007 Jan; 51(1):67-80. PubMed ID: 16844720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitization and chronic beryllium disease at a primary manufacturing facility, part 3: exposure-response among short-term workers.
    Schuler CR; Virji MA; Deubner DC; Stanton ML; Stefaniak AB; Day GA; Park JY; Kent MS; Sparks R; Kreiss K
    Scand J Work Environ Health; 2012 May; 38(3):270-81. PubMed ID: 21877099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beryllium sensitization, chronic beryllium disease, and exposures at a beryllium mining and extraction facility.
    Deubner D; Kelsh M; Shum M; Maier L; Kent M; Lau E
    Appl Occup Environ Hyg; 2001 May; 16(5):579-92. PubMed ID: 11370937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization and assessment of dermal and inhalable nickel exposures in nickel production and primary user industries.
    Hughson GW; Galea KS; Heim KE
    Ann Occup Hyg; 2010 Jan; 54(1):8-22. PubMed ID: 19759172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beryllium Exposure Control Program at the Cardiff Atomic Weapons Establishment in the United Kingdom.
    Johnson JS; Foote K; McClean M; Cogbill G
    Appl Occup Environ Hyg; 2001 May; 16(5):619-30. PubMed ID: 11370940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beryllium aerosol characteristics in the magnesium and aluminum transformation industry in Quebec: a comparison of four different sampling methodologies.
    Dufresne A; Dion C; Viau S; Cloutier Y; Perrault G
    J Occup Environ Hyg; 2009 Nov; 6(11):687-97. PubMed ID: 19757293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Occupational exposure to beryllium in primary aluminium production.
    Skaugset NP; Ellingsen DG; Dahl K; Martinsen I; Jordbekken L; Drabløs PA; Thomassen Y
    J Environ Monit; 2012 Feb; 14(2):353-9. PubMed ID: 21993554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beryllium surface levels in a military ammunition plant.
    Sanderson WT; Leonard S; Ott D; Fuortes L; Field W
    J Occup Environ Hyg; 2008 Jul; 5(7):475-81. PubMed ID: 18569510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Particle size distribution and respiratory deposition estimates of beryllium aerosols in an extraction and processing plant.
    Thorat DD; Mahadevan TN; Ghosh DK
    AIHA J (Fairfax, Va); 2003; 64(4):522-7. PubMed ID: 12908869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Historical analysis of airborne beryllium concentrations at a copper beryllium machining facility (1964-2000).
    McAtee BL; Donovan EP; Gaffney SH; Frede W; Knutsen JS; Paustenbach DJ
    Ann Occup Hyg; 2009 Jun; 53(4):373-82. PubMed ID: 19383942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations of Metrics of Peak Inhalation Exposure and Skin Exposure Indices With Beryllium Sensitization at a Beryllium Manufacturing Facility.
    Virji MA; Schuler CR; Cox-Ganser J; Stanton ML; Kent MS; Kreiss K; Stefaniak AB
    Ann Work Expo Health; 2019 Oct; 63(8):856-869. PubMed ID: 31504146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultrafine beryllium number concentration as a possible metric for chronic beryllium disease risk.
    McCawley MA; Kent MS; Berakis MT
    Appl Occup Environ Hyg; 2001 May; 16(5):631-8. PubMed ID: 11370941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Process-related risk of beryllium sensitization and disease in a copper-beryllium alloy facility.
    Schuler CR; Kent MS; Deubner DC; Berakis MT; McCawley M; Henneberger PK; Rossman MD; Kreiss K
    Am J Ind Med; 2005 Mar; 47(3):195-205. PubMed ID: 15712254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of physicochemical properties of beryllium aerosols associated with prevalence of chronic beryllium disease.
    Stefaniak AB; Hoover MD; Day GA; Dickerson RM; Peterson EJ; Kent MS; Schuler CR; Breysse PN; Scripsick RC
    J Environ Monit; 2004 Jun; 6(6):523-32. PubMed ID: 15173904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.